Alere (ALR) Announces FDA Marketing Clearance for Alere i Strep A Rapid Molecular Test
Tweet Send to a Friend
Alere (NYSE: ALR) announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
